Acupuncture for Functional Dyspepsia: a Functional Magnetic Resonance Imaging (fMRI) Study

He-Mu-point combination(ST36 and CV12) is one of the most commonly used acupoints combination with synergistic effect for functional dyspepsia(FD). The investigators design the trial to identify the efficacy and explore the central integrated mechanism of puncturing at He-Mu-point combination on FD with functional magnetic resonance imaging (fMRI).

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

105 participants with functional dyspepsia will be allocated into three groups: Low-He point group, Mu point group and He-Mu-point combination group.Every participant will receive 20 sessions of manual acupuncture treatment during 4 weeks. Clinical evaluations will be assessed three times, as measured after randomization, 10 and 20 sessions of treatment.The fMRI scans will be conducted twice, after randomization and treatment completion.

Study Type

Interventional

Enrollment (Actual)

105

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sichuan
      • Chengdu, Sichuan, China, 610000
        • Chengdu University of Traditional Chinese Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. right handed,age between 18 and 45 years old, college degree or above;
  2. match the Rome III criteria on FD;
  3. no local organic disease by gastroscope examination;
  4. before entering the study, without taking any prokinetic agents at least 15days and participating in other clinical study;
  5. signing an informed consent in writing by the participant or the immediate family member.

Exclusion Criteria:

  1. consciousness, cannot express subjective symptoms and psychiatric participants;
  2. participants with advanced cancer or other serious wasting diseases, easy to be infected and bleeding;
  3. complicating with severe cardiovascular, hepatic,nephritic,digestive, hematopoietic system diseases;
  4. impregnate or lactation female;
  5. severe depression and anxiety symptoms;
  6. female with serious dysmenorrhea;
  7. obvious headache, migraine, history of head injury.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Low-He point(ST36)
Zusanli (ST36, the Low-He point of stomach) is the most important point for gastrointestinal disorder, including functional dyspepsia. Everyone in the group will be punctured at unilateral Zusanli.
Manual acupuncture treatment will be conducted. thirty minutes duration every time, five times per week for one course, a total four courses.
Other Names:
  • Manual acupuncture
Experimental: Mu point(CV12)
Zhongwan (CV12, the Mu point of stomach) is also good at regulating gastric function. Everyone in the group will be punctured at Zhongwan.
Manual acupuncture treatment will be conducted. thirty minutes duration every time, five times per week for one course, a total four courses.
Other Names:
  • Manual acupuncture
Active Comparator: He-Mu-point combination(ST36 and CV12)
In traditional Chinese acupuncture theory,synergistic effect can be produced by acupoints combination and the He-Mu-point combination is a classical acupoints combination formula for gastrointestinal diseases. Everyone in the group will be punctured at unilateral Zusanli and Zhongwan.
Manual acupuncture treatment will be conducted. thirty minutes duration every time, five times per week for one course, a total four courses.
Other Names:
  • Manual acupuncture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Nepean Dyspepsia Index (NDI)
Time Frame: 4 weeks after allocation
4 weeks after allocation

Secondary Outcome Measures

Outcome Measure
Time Frame
Self-Rating Anxiety Scale
Time Frame: 0 day,2, 4weeks after allocation
0 day,2, 4weeks after allocation
Self-Rating Depression Scale
Time Frame: 0 day,2, 4weeks after allocation
0 day,2, 4weeks after allocation
Leeds dyspepsia questionnaire
Time Frame: 0 day,4 weeks after allocation
0 day,4 weeks after allocation
brain MRI data
Time Frame: 0 day,4weeks after allocation
0 day,4weeks after allocation
The incidence of adverse events during the 4 weeks
Time Frame: 4weeks after allocation
4weeks after allocation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Fang Zeng, professor, Chengdu University of Traditional Chinese Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

December 1, 2017

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

December 15, 2016

First Submitted That Met QC Criteria

December 15, 2016

First Posted (Estimate)

December 19, 2016

Study Record Updates

Last Update Posted (Actual)

April 6, 2018

Last Update Submitted That Met QC Criteria

April 5, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 15QNJJ0008
  • 81473602 (Other Grant/Funding Number: National Scientific Foundation Committee of China)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Functional Dyspepsia

Clinical Trials on acupuncture

3
Subscribe